Guggenheim Capital’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$896K Buy
18,338
+2,317
+14% +$113K 0.01% 928
2025
Q1
$816K Sell
16,021
-3,465
-18% -$177K 0.01% 962
2024
Q4
$880K Sell
19,486
-5,661
-23% -$256K 0.01% 979
2024
Q3
$933K Buy
25,147
+734
+3% +$27.2K 0.01% 1139
2024
Q2
$747K Sell
24,413
-5,629
-19% -$172K 0.01% 1252
2024
Q1
$874K Sell
30,042
-1,577
-5% -$45.9K 0.01% 1247
2023
Q4
$871K Buy
31,619
+5,285
+20% +$146K 0.01% 1222
2023
Q3
$590K Buy
26,334
+1,800
+7% +$40.3K 0.01% 1339
2023
Q2
$998K Buy
24,534
+1,298
+6% +$52.8K 0.01% 1158
2023
Q1
$1.13M Buy
+23,236
New +$1.13M 0.01% 1122
2021
Q4
Sell
-36,280
Closed -$1.35M 2198
2021
Q3
$1.35M Sell
36,280
-254
-0.7% -$9.45K 0.01% 1262
2021
Q2
$1.54M Buy
36,534
+3,017
+9% +$128K 0.01% 1249
2021
Q1
$1.59M Sell
33,517
-150
-0.4% -$7.1K 0.01% 1149
2020
Q4
$2.06M Sell
33,667
-10,399
-24% -$635K 0.01% 951
2020
Q3
$2.06M Sell
44,066
-7,690
-15% -$359K 0.01% 876
2020
Q2
$2.63M Buy
51,756
+5,421
+12% +$275K 0.02% 763
2020
Q1
$2.07M Sell
46,335
-9,084
-16% -$405K 0.02% 774
2019
Q4
$2.66M Sell
55,419
-1,531
-3% -$73.5K 0.02% 925
2019
Q3
$1.93M Buy
56,950
+53
+0.1% +$1.79K 0.02% 1034
2019
Q2
$2.56M Sell
56,897
-14,810
-21% -$666K 0.02% 951
2019
Q1
$2.7M Buy
71,707
+7,405
+12% +$279K 0.02% 944
2018
Q4
$2.21M Buy
+64,302
New +$2.21M 0.02% 994
2018
Q2
Sell
-65,289
Closed -$1.77M 2545
2018
Q1
$1.77M Sell
65,289
-21,619
-25% -$585K ﹤0.01% 1723
2017
Q4
$1.45M Buy
+86,908
New +$1.45M ﹤0.01% 1874
2016
Q2
Sell
-166,541
Closed -$1.07M 2920
2016
Q1
$1.07M Buy
166,541
+115,384
+226% +$743K ﹤0.01% 2003
2015
Q4
$1.66M Buy
+51,157
New +$1.66M ﹤0.01% 1752
2015
Q3
Sell
-135,389
Closed -$6.52M 3017
2015
Q2
$6.52M Buy
135,389
+44,232
+49% +$2.13M 0.02% 1032
2015
Q1
$5.55M Buy
91,157
+1,040
+1% +$63.3K 0.01% 1116
2014
Q4
$4.67M Buy
+90,117
New +$4.67M 0.01% 1157